NewsBenzingaRBC Capital Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $125 RBC Capital Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $125 Benzinga 2026.11.05 20:15 (GMT+0) Open on Benzinga Other news Binance to Distribute IBM, AAPL, GLW and LLY Dividends via bStocks Core Scientific Plans to Fully Exit Bitcoin Mining Business by End of 2026 OpenAI Renames Data Centers as "Compute Parks" This Insurance Stock Just Raised Its Dividend by Over 11% Hollywood Film Studios Bar Employees From Using Insider Information to Bet on Prediction Markets UBS Maintains Buy on CDW, Raises Price Target to $195
